Work

SEAPORT 1: An Open-label Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Participants with ESKD Undergoing Hemodialysis: Interim Analysis

Year: 2024

Type: article

Study design: Clinical Trial

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.2024zx8xfw88

Authors: Asghar A. Chaudhry, Steven Zeig, Bruce Jeffrey Fisch, Yves Sabbagh, Kurt C. Gunter, Sagar U. Nigwekar

Institutions: Inozyme Pharma (United States), Massachusetts General Hospital

Language: English

Topic: Parathyroid Disorders and Treatments

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403833583

FWCI:

Cites:

Cited by:

Related to: 10